Tuesday, April 20, 2021 5:10:24 PM
An NRX announcement of USFDA filing and a meeting date will be a good start.
RLF should be in a process with AdVita / Swissmedica to NOW FINALLY file some applications at EMA as the data is available.
At least they stopped the bleeding from the 'self inflicted' bs with the 'leak'. It would be Great if the RLF-100 Inhaler version/(60 day)formulation Trials in Europe gets attention before NRX's 1 year shelf life stuff. An unneeded costly delay add-on, IMO...GLTA...
https://www.fda.gov/media/72253/download
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM